Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice

被引:104
作者
Ishida, T
Ichikawa, T
Ichihara, M
Sadzuka, Y
Kiwada, H
机构
[1] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Pharmacokinet & Biopharmaceut, Tokushima 7708505, Japan
[2] Univ Shizuoka, Sch Pharmaceut Sci, Dept Pharmaceut Engn, Shizuoka 4228526, Japan
关键词
accelerated blood clearance; liposomes; repeated injection; polyethylene glycol (PEG);
D O I
10.1016/j.jconrel.2003.12.011
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Using mice as a model, we recently reported that the long-circulating properties of polyethylene glycol (PEG) (M. W. 2000)modified liposomes (mPEG(2000)-liposomes) disappeared when they were intravenously injected at certain intervals [referred to as the "accelerated blood clearance (ABC) phenomenon"]. Herein, we report on a study of issue of whether physicochemical properties of a prior dose of liposomes such as degree of PEGylation, PEG chain length, lipid dose, surface charge, size, play a role in inducing this phenomenon. The injection of conventional liposomes (without a PEG-coating) significantly induced the phenomenon. The PEGylation of conventional liposomes attenuated the induction of the phenomenon somewhat with increasing molar content of PEG derivative and PEG chain length. These findings clearly suggest that the PEGylation of liposomes are not the major cause of the ABC phenomenon but, rather, played a role in preventing it. In addition, increasing the lipid dose in a prior dose of mPEG(2000)-liposomes (0-25 mumol/kg) increased the induction of the phenomenon in a sigmoid manner. The surface charge and size of the liposomes were not critical for the induction of the phenomenon, although generally these serve as determinants in the biodistribution of liposomes. The results reported here clearly indicate that the physicochemical properties of a prior dose of liposomes strongly affect the pharmacokinetic behavior of a subsequent injection of mPEG(2000)-liposomes: The extent of PEGylation and the lipid dose had an effect, but the surface charge and size did not. The results reported herein have a considerable impact on the design and engineering of liposomal formulations for use in multiple drug therapy as well as in therapy that involves the use of liposomal drugs. (C) 2004 Elsevier B.V All rights reserved.
引用
收藏
页码:403 / 412
页数:10
相关论文
共 43 条
[1]   Liposome targeting in animal models: Problems and opportunities [J].
Allen, TM .
JOURNAL OF LIPOSOME RESEARCH, 1997, 7 (04) :315-329
[2]   PHARMACOKINETICS OF LONG-CIRCULATING LIPOSOMES [J].
ALLEN, TM ;
HANSEN, CB ;
DEMENEZES, DEL .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :267-284
[3]   PHARMACOKINETICS OF STEALTH VERSUS CONVENTIONAL LIPOSOMES - EFFECT OF DOSE [J].
ALLEN, TM ;
HANSEN, C .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1068 (02) :133-141
[4]   Liposomal drug formulations - Rationale for development and what we can expect for the future [J].
Allen, TM .
DRUGS, 1998, 56 (05) :747-756
[5]   LONG-CIRCULATING (STERICALLY STABILIZED) LIPOSOMES FOR TARGETED DRUG-DELIVERY [J].
ALLEN, TM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :215-220
[6]  
ALLEN TM, 1984, LIPOSOMES THERAPY IN, V3, P205
[7]  
[Anonymous], INT J CANC
[8]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[9]  
BATIST G, 2003, EXPERT OPIN PHARMACO, P1739
[10]   LIPOSOMAL DOXORUBICIN-INDUCED TOXICITY - DEPLETION AND IMPAIRMENT OF PHAGOCYTIC-ACTIVITY OF LIVER MACROPHAGES [J].
DAEMEN, T ;
HOFSTEDE, G ;
KATE, MTT ;
BAKKERWOUDENBERG, IAJM ;
SCHERPHOF, GL .
INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (05) :716-721